This compound is primarily utilized in the field of medicinal chemistry as an intermediate in the synthesis of more complex molecules. Its structure, featuring a difluoro and azabicyclo component, makes it valuable for developing pharmaceuticals, particularly those targeting neurological disorders. The compound's unique bicyclic framework can enhance the binding affinity and selectivity of drug candidates to specific biological targets. Additionally, it is explored in the development of enzyme inhibitors, where its structural rigidity and fluorine atoms can improve metabolic stability and bioavailability. Researchers also investigate its potential in creating novel therapeutic agents for conditions such as chronic pain, depression, and anxiety, leveraging its ability to interact with central nervous system receptors.